Revance Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by State Street Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $5.9M | 2.3M | 2.57 |
2024-03-31 | $12M | 2.4M | 4.92 |
2023-12-31 | $22M | 2.5M | 8.79 |
2023-09-30 | $27M | 2.3M | 11.47 |
2023-06-30 | $52M | 2.1M | 25.31 |
2023-03-31 | $63M | 1.9M | 32.21 |
2022-12-31 | $38M | 2.0M | 18.46 |
2022-09-30 | $44M | 1.6M | 27.00 |
2022-06-30 | $25M | 1.8M | 13.82 |
2022-03-31 | $30M | 1.5M | 19.50 |
2021-12-31 | $26M | 1.6M | 16.32 |
2021-09-30 | $42M | 1.5M | 27.86 |
2021-06-30 | $43M | 1.4M | 29.64 |
2021-03-31 | $38M | 1.4M | 27.95 |
2020-12-31 | $42M | 1.5M | 28.34 |
2020-09-30 | $34M | 1.3M | 25.14 |
2020-06-30 | $33M | 1.4M | 24.42 |
2020-03-31 | $17M | 1.2M | 14.80 |
2019-12-31 | $17M | 1.1M | 16.23 |
2019-03-31 | $13M | 813k | 15.76 |
2018-12-31 | $14M | 676k | 20.13 |
2018-09-30 | $18M | 720k | 24.85 |
2018-06-30 | $18M | 669k | 27.45 |
2018-03-31 | $18M | 593k | 30.80 |
2017-12-31 | $17M | 461k | 35.74 |
2017-09-30 | $13M | 466k | 27.55 |
2017-06-30 | $12M | 453k | 26.40 |
2017-03-31 | $9.4M | 450k | 20.80 |
2016-12-31 | $6.7M | 325k | 20.70 |
2016-09-30 | $5.0M | 308k | 16.22 |
2016-06-30 | $5.8M | 430k | 13.60 |
2016-03-31 | $9.2M | 527k | 17.46 |
2015-12-31 | $13M | 389k | 34.16 |
2015-09-30 | $6.7M | 226k | 29.78 |
2015-06-30 | $6.2M | 193k | 32.01 |
2015-03-31 | $2.3M | 111k | 20.71 |
2014-12-31 | $1.8M | 104k | 16.93 |
2014-09-30 | $1.9M | 99k | 19.36 |
2014-06-30 | $3.1M | 91k | 34.01 |
2014-03-31 | $2.1M | 66k | 31.50 |